ABSTRACT
INTRODUCTION

Tuberculosis (TB) in association with
Human Immuno Virus (HIV) is a major alarm in the health care system, Mycobacterium tuberculosis in coordination with HIV enhances the descent of immunological functions and pathogenicity of one another leading to death if left untreated 1 . The mechanism involved in the progression and the impact of HIV TB co-infection on host's immune system has not been understood completely. The progression has been influenced by factors such as inborn errors of immunity and genetic polymorphisms. 
Epidemiology
It was estimated that the risk of developing TB was between 26 and 31 times higher in individuals affected with HIV. About 36.7 million people were living with human immunodeficiency virus infection by the end of 2015 (PLHIV) and 2.1 million people became newer targets for HIV. About 1.1 million people died as a result of diseases related to Acquired Immuno Deficiency Virus (AIDS). 2 Tuberculosis accounts for death in one in every three individuals with Acquired Immuno Deficiency Syndrome (AIDS) related illnesses. 3 The incidence of HIV TB co-infection in India was about 2,840 thousands and the mortality due this co-infection was about 37 thousands as per the estimation of WHO done in 2015.
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Pathophysiology of TB
The pathophysiological processes of TB involve partaking of both innate and cell mediated immunity. The innate immune responses involve active connexion of macrophages and dendritic cells (DC) whereas the cell mediated immunity involves the predominance of T lymphocytes. The prime targets for Tuberculosis are macrophages present in the alveoli. 1 The pathogen within the macrophage will be detected by the toll like receptors (TLR) and nucleotide binding oligomerization domain receptors of innate cells, which initiate local inflammatory response. The inflammatory response is characterized by activation of macrophages and dendritic cells. The activated macrophages release reactive oxygen and nitrogen intermediates and elevate the expression of GTPases. 1 The dendritic cells are involved in the phagocytosis of the pathogen in the tissues of the lung. The DCs will also drift to the lymph nodes triggering T lymphocyte mediated adaptive immunity. 
HIV -TB Co-Infection
HIV infection causes a rapid decline of immune responses resulting in multiplication of the mycobacterium with in the granuloma leading to reactivation of the infection. It was also theorized that there will be an increased replication of HIV at the sites of mycobacterium infection by multiplying within the activated CD4 + T cells and the macrophages accumulating at the site of granuloma. The death of CD4 + T cells within the granuloma also causes the reactivation of the infection. Thus HIV infected individuals with lower CD4 counts are more susceptible for attaining TB rather than individual with higher CD4 counts. 5 Prompt evidence suggests that there are decreased levels of CD4 cells and increased viral load in bronchoalveloar lavage as well as in pleural fluid in HIV TB co-infected individuals than in TB infected individuals. Various in vitro studies demonstrate that the pro-inflammatory cytokines such as TNF alpha, IL 1 β, and IL 6 produced by the phagocytosis of mycobacterium aid in the multiplication of HIV-1. Thus HIV TB co-infection is associated with reduced survivability of macrophages and elevated pro-inflammatory cytokines creates a symbiotic environment for the coexistence of both the pathogens. 5 Thus estimating the CD4 count status will aid in depiction of the clinical condition in patients with HIV/ AIDS. The CD4 counts also act as an index for the identification, assessment and induction of prophylactic therapies for various opportunistic infections (OIs) in high risk individuals.
AIM OF THE STUDY
The aim of the study is to determine the manifestations of HIV TB co-infection presenting as either pulmonary tuberculosis (PTB) or extra pulmonary tuberculosis (EPTB) and also co-relating the mean CD4 counts with age and gender of the affected individuals.
METHODOLOGY
A cross sectional study was conducted at the antiretroviral therapy (ART) centre of Sri Ram Narayan Ruia Government General Hospital (SVRRGGH), Tirupathi for a period of six months from October, 2015 to April 2016. Among a total of 1074 HIV positive individuals attending the ART centre for regular follow up, 324 individuals were found to be associated with TB as co-infection. Data about patient's age, gender, diagnosis of TB, TB manifestations and CD4 counts at the time of TB diagnosis were collected. All the patient above the age of 18 years diagnosed positive for HIV and TB were included in the study. The patients though diagnosed positive for TB but taking treatment outside the ART centre and patients not willing to participate in the study were excluded from the study.
RESULTS
Among 1074 individuals participated in the study, 334 individuals were associated with HIV TB coinfection. The prevalence of TB was found to be 31.09% with PTB in 226 (67.66%) and EPTB in 108 (32.33%) individuals. The most commonly affected age group was 18 -45 years of age in both PTB and EPTB. Males (131, 57.96%) were mostly affected in PTB whereas females (61, 56.48%) were commonly affected in EPTB. The age and gender wise distributions were depicted in the Tables 1 and 2 Table 4 given below shows the differences in mean CD4 counts and age of presentation in both the genders of the affected population.
DISCUSSION
In the present study, the prevalence of TB was found to be 31.09% which was not analogous to the findings of Alfred Muremo et al., who reported a higher prevalence. A similar prevalence of TB as in our observation was reported by Surendra KS et al. This change in prevalence can be attributed to the screening of TB and also various other factors such as gender, educational status, residence, occupational status, marital status, CD4 count level and WHO clinical staging. 6, 7 It was observed that PTB constituted 67.66% and EPTB constituted 32.33% of the study population which was comparable to the findings of Ketki Jangid et al., Nara et al., and Alfred Muremo et al. [6] [7] [8] Our findings were in contrast to those of Harapriya Kar et al., and Kavya S et al., 10, 11 Usually the incidence of EPTB was more in AIDS as related immunodeficiency inclines to manifest as atypical TB and is also associated with dissemination outside the lung when compared to individuals without HIV. 12 The mean age of presentation was equivalent to the findings made by Aghor Ako et al. 12 The age of presentation of EPTB was less when compared to PTB in our study though there is no demarcated difference. The most commonly affected age group was 18 -45 years in both PTB and EPTB which was similar to the outcomes seen by Nara et al. and Siddeshwari et al. [9] [10] [11] [12] [13] Usually age > 35 years, cough > 2 weeks duration, night sweats, severe wasting, presence of pleural effusion, positive HIV status and anemia were considered as the predictors of TB. In concern to the gender wise distribution majority of the males were affected with PTB and females were affected with EPTB which was in co-relation with the observations of Aghor AKO et al. 12 and the mean age was less in females when compared to males for both PTB and EPTB. Usually women were found to have higher susceptibility to HIV infection and were exposed to sexual activity earlier than men and also being HIV positive for 10 years was considered to be a risk factor for presentation of EPTB [9] [10] [11] [12] So, this contributes to the practical inference that women were presenting at younger ages than men and were more susceptible to EPTB than men.
The mean CD4 counts in EPTB were more to that in PTB and the mean counts were comparable with the findings of Ketki Jangid et al. 8 But the mean CD4 counts for EPTB were lesser than PTB which was not in accordance with our findings. The decline in the CD4 counts at the time of diagnosis can be considered as the indication for the presence of OI and also as a marker for the symbiotic association between TB and HIV. The studies performed by Kavya S et al, Nara et al. [9] [10] [11] stated that EPTB was most commonly observed when the CD4 counts were <200 cells/mm 3 . Also EPTB presenting as meningitis and CD4 T cells <200 cells/mm 3 were considered as the increased risk factors for mortality 6 . But, in our study the mean CD4 counts for EPTB were 237.65 cells/mm 3 which should be considered as a determining factor for diagnosis and needs to be correlated with the clinical findings.
CONCLUSION
In HIV positive individuals TB still remains to be the commonly observed opportunistic infection presenting even at higher CD4 counts. The health care professionals should consider differential diagnosis for TB as most of the individuals present with smear negativity. Employing culture sensitivity tests and gene expert tests in individuals with potential risk factors should be considered. There is a need to implement prophylactic therapies in high risk individuals by considering symptomology and clinical staging. Individuals receiving prophylactic regimens had a lower risk of mortality. There is also a prompt necessity to conduct mass screening programmes to detect newer cases of TB in HIV infected individuals.
